Bluechiip Limited Stock Market Press Releases and Company Profile
Bluechiip Sells Tracking Starter Kit to Chinese Centre
Bluechiip Sells Tracking Starter Kit to Chinese Centre

Sydney, Aug 1, 2016 AEST (ABN Newswire) - Bluechiip Limited (googlechartASX:BCT), a leader in the development of sample tracking technology for harsh environments, today announced the sale of a Starter Kit to the Chinese Centre for Disease, Control and Prevention (CCDC), based in Beijing.

The CCDC is an agency of the Chinese Ministry of Health. It protects public health and safety by providing information to enhance health decisions, and promotes health through partnerships with provincial health departments and other organizations. The CCDC focuses national attention on developing and applying disease prevention and control, environmental health, occupational health and safety, health promotion, prevention and education activities designed to improve the health of Chinese people.

The sale of the Starter Kit continues Bluechiip's progression in China, with systems now including both English and Chinese interfaces.

The Starter Kit, which includes a Bluechiip reader and 3,000 associated consumables, allows CCDC to become familiar with Bluechiip's technology and to train staff in its use. Starter Kits are the first step toward a successful rollout of the full suite of product.

Bluechiip CEO Andrew McLellan said the sale to CCDC confirms the value of Bluechiip's technology to OEM partners and end customers that need to effectively control sample integrity through the chain of custody.

"The sale continues Bluechiip's recent momentum of kit sales to partners. Having Bluechiip systems in leading institutions such as CCDC provides a reference point for both OEM partners and end users who watch and follow closely the leaders in the space."

Earlier this month Bluechiip successfully displayed its tracking technology at the European Society of Human Reproductive Embryology (ESHRE) trade show in Helsinki, Finland. ESHRE's four-day trade show is the world's largest for assistive reproductive technologies (ART), attracting more than 10,000 attendees and hundreds of major vendors presenting new products and technologies for the in vitro fertilization market.

About Bluechiip Limited

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

 

https://twitter.com/bluechiip https://www.youtube.com/channel/UCaVcyO4O2oJ_9fLdMs6JIyQ https://www.linkedin.com/company/bluechiip-limited abnnewswire.com 


Contact

Corporate enquiries
Andrew McLellan
Managing Director - CEO
Ph: +61-457-823-470
andrew.mclellan@bluechiip.com

Media
Richard Allen
Ph: +61-3-9915-6341
Oxygen Financial PR
richard@oxygenpr.com.au



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 3) (Last 30 Days: 21) (Since Published: 3075)